Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Bupivacaine liposomal hydrogel encapsulated - Virpax Pharmaceuticals/Lipocure

Next Previous
Drug Profile

Bupivacaine liposomal hydrogel encapsulated - Virpax Pharmaceuticals/Lipocure

Alternative Names: Bupigel; Bupisome; LBL 100; LC-400; LMVV bupivacaine; Probudur™

Latest Information Update: 28 May 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator LipoCure
  • Developer LipoCure; Virpax Pharmaceuticals
  • Class Amides; Analgesics; Anilides; Anti-inflammatories; Local anaesthetics; Non-opioid analgesics; Piperidines; Small molecules; Xylenes
  • Mechanism of Action Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • No development reported Postoperative pain

Most Recent Events

  • 28 May 2025 No recent reports of development identified for phase-I development in Postoperative-pain(In volunteers) in Israel (Injection, Controlled release)
  • 28 May 2025 No recent reports of development identified for preclinical development in Postoperative-pain in Germany (Injection, Controlled release)
  • 18 Mar 2025 Pharmacodynamics data from preclinical trial in Postoperative pain released by Virpax

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top